NYSEARCA:SBIO ALPS Medical Breakthroughs ETF (SBIO) Price, Holdings, & News → Move Your Money Before May 22 (From Stansberry Research) (Ad) Free SBIO Stock Alerts $31.65 +0.12 (+0.38%) (As of 04/26/2024 ET) Add Compare Share Share Today's Range$31.65▼$32.1550-Day Range$31.53▼$38.6952-Week Range$23.21▼$38.80Volume3,934 shsAverage Volume12,408 shsMarket Capitalization$101.28 millionAssets Under Management$100.74 millionDividend Yield0.21%Net Expense Ratio0.50% Stock AnalysisStock AnalysisChartHeadlinesHoldingsOwnershipRatingsStock AnalysisChartHeadlinesHoldingsOwnershipRatings Get ALPS Medical Breakthroughs ETF alerts: Email Address About ALPS Medical Breakthroughs ETF (NYSEARCA:SBIO)The ALPS Medical Breakthroughs ETF (SBIO) is an exchange-traded fund that is based on the S-Network Medical Breakthroughs index. The fund tracks, a market-cap weighted index comprising US-listed biotech companies with one or more drugs currently in either Phase II or Phase III FDA clinical trials. SBIO was launched on Dec 31, 2014 and is managed by ALPS.Read More SBIO Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart SBIO ETF News HeadlinesApril 17, 2024 | finance.yahoo.comALPS Medical Breakthroughs ETF (SBIO)February 22, 2024 | benzinga.comALPS ETF Trust ALPS Intermediate Municipal Bond ETF (ARCA:MNBD) Dividends: History, Yield and DatesApril 26, 2024 | Stansberry Research (Ad)Move Your Money Before May 22The SIX WORDS That Could Destroy America... And The Value of Your Savings. He predicted the dangerous rise of inflation... the death of the 60/40 portfolio... and now, this 40-year market veteran and retirement expert is stepping forward with a new must-see warning for every American. It involves the world's most powerful investors, central bankers, and America's most bitter geopolitical rivals. February 11, 2024 | msn.comI checked into a £40,000-a-week rehab in the Swiss AlpsJanuary 19, 2024 | seekingalpha.comHow ETF Investors Can Take Advantage Of Deal ActivityDecember 30, 2023 | finance.yahoo.comBiotech ETF SBIO’s Momentum Strong to End 2023December 22, 2023 | msn.comALPS Medical Breakthroughs ETF declares annual distribution of $0.0711December 10, 2023 | finance.yahoo.comPlay US Gene Treatment Approval in SBIOApril 26, 2024 | Stansberry Research (Ad)Move Your Money Before May 22The SIX WORDS That Could Destroy America... And The Value of Your Savings. He predicted the dangerous rise of inflation... the death of the 60/40 portfolio... and now, this 40-year market veteran and retirement expert is stepping forward with a new must-see warning for every American. It involves the world's most powerful investors, central bankers, and America's most bitter geopolitical rivals. September 12, 2023 | finance.yahoo.comSBIO - ALPS Medical Breakthroughs ETFSee More Headlines Receive SBIO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for ALPS Medical Breakthroughs ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address Fund Details IssuerALPS Fund NameALPS Medical Breakthroughs ETF Tax ClassificationRegulated Investment Company Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:SBIO Inception Date12/31/2014 Fund ManagerRyan Mischker, Andrew Hicks WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkS-Network Medical Breakthroughs Index CategorySector FocusHealth Care Development LevelDeveloped Markets RegionNorth America Number of Holdings97 Fund Statistics Assets Under Management$100.74 million Average Daily Volume$11,567.70 Discount/Premium0.05% Administrator, Advisor and Custodian AdministratorALPS Fund Services, Inc. AdvisorALPS Advisors, Inc. CustodianState Street Bank and Trust Company DistributorALPS Portfolio Solutions Distributor, Inc. Transfer AgentState Street Bank and Trust Company TrusteeN/A Lead Market MakerGTS Options OptionableN/A Short Interest5,100 shs Miscellaneous Outstanding Shares3,200,000Beta1.03 Creation Unit50,000 Creation Fee$500.00 Ten Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free Report Ad Stansberry ResearchMove Your Money Before May 22The SIX WORDS That Could Destroy America... And The Value of Your Savings. He predicted the dangerous rise of inflation... the death of the 60/40 portfolio... and now, this 40-year market veteran and retirement expert is stepping forward with a new must-see warning for every American. It involves the world's most powerful investors, central bankers, and America's most bitter geopolitical rivals. Here's where Dr. David Eifrig says to move your money immediately. ALPS Medical Breakthroughs ETF ExpensesTypeSBIOHealth Care ETFsEquity ETFsNYSEARCA ETFsAll ETFsManagement Fee0.50%0.56%0.54%0.50%0.51%Other Expenses0.00%0.40%0.54%0.64%0.58%Total Expense0.50%0.72%0.70%0.74%0.70%Fee Waiver0.00%-0.53%-0.55%-0.68%-0.57%Net Expense0.50%0.60%0.60%0.58%0.58% ALPS Medical Breakthroughs ETF (SBIO) Holdings & ExposureTop 10 SBIO HoldingsCerevel Therapeutics(NASDAQ:CERE)Holding Weight: 4.84%Viking Therapeutics(NASDAQ:VKTX)Holding Weight: 4.72%Vaxcyte(NASDAQ:PCVX)Holding Weight: 4.45%Revolution Medicines(NASDAQ:RVMD)Holding Weight: 3.91%Alpine Immune Sciences(NASDAQ:ALPN)Holding Weight: 2.68%Alkermes(NASDAQ:ALKS)Holding Weight: 2.65%Crinetics Pharmaceuticals(NASDAQ:CRNX)Holding Weight: 2.37%Axsome Therapeutics(NASDAQ:AXSM)Holding Weight: 2.15%SpringWorks Therapeutics(NASDAQ:SWTX)Holding Weight: 2.06%Xenon Pharmaceuticals(NASDAQ:XENE)Holding Weight: 2.06%SBIO Sector ExposureSBIO Industry ExposureFull Holdings Details Similar ETFsSimplify Propel Opportunities ETFNYSEARCA:SURIProShares Ultra Health CareNYSEARCA:RXLSimplify Health Care ETFNYSEARCA:PINKDirexion Daily S&P Biotech Bear 3X SharesNYSEARCA:LABDProShares Ultra Nasdaq BiotechnologyNASDAQ:BIBInstitutional OwnershipCentral Valley Advisors LLCBought 5,606 shares on 4/12/2024Ownership: 0.175%Virtu Financial LLCBought 15,725 shares on 2/26/2024Ownership: 0.453%Strategic Financial Services Inc Sold 44,548 shares on 2/8/2024Ownership: 0.573%NTV Asset Management LLCSold 12,526 shares on 2/6/2024Ownership: 0.941%Phoenix Wealth AdvisorsBought 1,130 shares on 1/30/2024Ownership: 0.315%View All Institutional Transactions SBIO ETF - Frequently Asked Questions How have SBIO shares performed in 2024? ALPS Medical Breakthroughs ETF's stock was trading at $32.94 at the start of the year. Since then, SBIO shares have decreased by 3.9% and is now trading at $31.65. View the best growth stocks for 2024 here. What does SBIO invest in? ALPS Medical Breakthroughs ETF is a equity fund issued by ALPS. SBIO focuses on health care investments and follows the S-Network Medical Breakthroughs Index. The fund's investments total to approximately $100.74 million assets under management. What stocks does ALPS Medical Breakthroughs ETF hold? SBIO invests in 97 holdings. Some of the stocks in their portfolio include Cerevel Therapeutics (CERE), Viking Therapeutics (VKTX), Vaxcyte (PCVX), Revolution Medicines (RVMD), Alpine Immune Sciences (ALPN), Alkermes (ALKS), Crinetics Pharmaceuticals (CRNX), Axsome Therapeutics (AXSM), SpringWorks Therapeutics (SWTX) and Xenon Pharmaceuticals (XENE). What is the management fee for ALPS Medical Breakthroughs ETF? ALPS Medical Breakthroughs ETF's management fee is 0.50% and has no other recorded expenses or fee waivers. The net expense ratio for SBIO is 0.50%. What other stocks do shareholders of ALPS Medical Breakthroughs ETF own? Based on aggregate information from My MarketBeat watchlists, some companies that other ALPS Medical Breakthroughs ETF investors own include Micron Technology (MU), Gilead Sciences (GILD), Inovio Pharmaceuticals (INO), Johnson & Johnson (JNJ), Novavax (NVAX), Alibaba Group (BABA), Cidara Therapeutics (CDTX) and Quest Diagnostics (DGX). Who are ALPS Medical Breakthroughs ETF's major shareholders? ALPS Medical Breakthroughs ETF's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Central Valley Advisors LLC (0.18%). How do I buy shares of ALPS Medical Breakthroughs ETF? Shares of SBIO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSEARCA:SBIO) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithFed launches fourth dollar overhaulStansberry ResearchMan Who Predicted 2008: “This Will be Worse.”AltimetryJeff Bezos Just Humiliated Elon MuskInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ALPS Medical Breakthroughs ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
